FMR LLC Reduces Stake in aTyr Pharma Inc. to 6.1%

FMR LLC filed a Schedule 13G/A on June 5, 2026, disclosing a significant reduction in its stake in aTyr Pharma Inc. (ATYR). As of the event date on May 29, 2026, FMR LLC reported beneficial ownership of 5,935,900 shares of common stock, representing a 6.1% ownership stake in the company. This represents a substantial decrease from its previously reported position of 14,706,843 shares. The filing indicates that FMR LLC holds sole dispositive power over all 5,935,900 shares and sole voting power over 5,932,912 shares. Abigail P. Johnson, as a Director, Chairman, and CEO of FMR LLC, is also listed as a reporting person with identical dispositive power. The securities were acquired in the ordinary course of business and are not held for the purpose of changing or influencing the control of the issuer. Various subsidiaries, including FIAM LLC and Fidelity Management & Research Company LLC, are identified as the relevant entities through which the shares are held. This filing marks the 14th amendment to FMR LLC's ownership disclosures for aTyr Pharma.